Hantz Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$111K Buy
1,387
+1,004
+262% +$82.8K ﹤0.01% 1255
2025
Q4
$33K Buy
383
+5
+1% +$410 ﹤0.01% 1586
2025
Q3
$29K Buy
378
+164
+77% +$12.8K ﹤0.01% 1429
2025
Q2
$17K Buy
214
+112
+110% +$8.35K ﹤0.01% 1325
2025
Q1
$7K Buy
102
+24
+31% +$1.72K ﹤0.01% 1049
2024
Q4
$6K Sell
78
-1,777
-96% -$124K ﹤0.01% 867
2024
Q3
$122K Sell
1,855
-457
-20% -$33.2K ﹤0.01% 596
2024
Q2
$214K Sell
2,312
-40
-2% -$3.54K ﹤0.01% 560
2024
Q1
$225K Sell
2,352
-71
-3% -$5.96K ﹤0.01% 557
2023
Q4
$185K Sell
2,423
-5,909
-71% -$411K ﹤0.01% 562
2023
Q3
$577K Buy
8,332
+5,704
+217% +$458K 0.01% 469
2023
Q2
$248K Buy
2,628
+151
+6% +$13.1K 0.01% 525
2023
Q1
$205K Buy
2,477
+570
+30% +$44.8K 0.01% 542
2022
Q4
$142K Buy
1,907
+95
+5% +$7.32K ﹤0.01% 555
2022
Q3
$150K Hold
1,812
0.01% 534
2022
Q2
$172K Sell
1,812
-261
-13% -$27K 0.01% 522
2022
Q1
$244K Buy
2,073
+279
+16% +$31.3K 0.01% 509
2021
Q4
$232K Hold
1,794
0.01% 498
2021
Q3
$203K Hold
1,794
0.01% 490
2021
Q2
$186K Hold
1,794
0.01% 460
2021
Q1
$150K Hold
1,794
0.01% 460
2020
Q4
$164K Buy
+1,794
New +$149K 0.01% 417

Other funds holding EW

Hantz Financial Services's EW Position: Q1 2026 in Review

Hantz Financial Services increased its Edwards Lifesciences (EW) stake by 262% in Q1 2026, buying an estimated $82.8K and bringing the position to 1,387 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

Hantz Financial Services first reported a position in EW in Q4 2020 and has held it in 22 quarters since. The position peaked at $577K in Q3 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Hantz Financial Services held 1,387 shares of Edwards Lifesciences worth $111K as of Q1 2026.
  • Hantz Financial Services bought 1,004 Edwards Lifesciences shares in Q1 2026, an estimated $82.8K.
  • Edwards Lifesciences made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #1255 holding.
  • Hantz Financial Services first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 22 quarters since.
  • Hantz Financial Services's Edwards Lifesciences position peaked at $577K in Q3 2023.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.